Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.

导出 OA

翻译打印收藏纠错

第一作者： Yasuaki,Mizutani

第一单位： Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakugo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.

作者： Yasuaki,Mizutani ^[1] ; Reiko,Ohdake ^[1] ; Harutsugu,Tatebe ^[2] ; Atsuhiro,Higashi ^[1] ; Sayuri,Shima ^[1] ; Akihiro,Ueda ^[1] ; Mizuki,Ito ^[1] ; Takahiko,Tokuda ^[2] ; Hirohisa,Watanabe ^[3]

作者单位： Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakugo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. ^[1] Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Chiba, Japan. ^[2] Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakugo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. hirohisa.watanabe@fujita-hu.ac.jp. ^[3]

关键词 Alzheimer’s disease (AD)Cognitive impairment Parkinson’s disease (PD)Plasma biomarker

主题词人类(Humans);帕金森病(Parkinson Disease);阿尔茨海默病(Alzheimer Disease);痴呆(Dementia);淀粉样β肽类(Amyloid beta-Peptides);tau蛋白质类(tau Proteins);Lewy体病(Lewy Body Disease)

DOI 10.1007/s00415-023-11875-z

PMID 37480401

发布时间 2023-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交